静脉注射免疫球蛋白在肝素诱导的血小板减少症内皮化疾病模型中预防血栓形成
本研究在微流控通道中培养人脐静脉内皮细胞并用TNF-α激活,全血暴露于普通肝素联合或不联合静脉注射免疫球蛋白(IVIG),再以HIT样单克隆抗体K070或HIT患者IgG处理,在静脉剪切应力下灌注观察血栓形成。结果显示HIT患者IgG和K070在预防性肝素暴露下诱导血栓形成,而IVIG预处理显著减少细胞黏附并预防血栓形成。
要点
- HIT患者IgG和K070在预防性肝素暴露下于TNF-α激活的内皮细胞上诱导血栓形成。
- HIT血栓富含纤维蛋白、携带磷脂酰丝氨酸的血小板和白细胞聚集体。
- IVIG预处理血液显著减少细胞黏附并预防血栓形成。
核心结论
- 内皮化体外流室系统有效再现了HIT的免疫血栓表型,为紧急验证IVIG干预对HIT患者IgG诱导血栓形成的疗效提供了可靠工具。
研究设计与样本
- 体外研究:微流控通道内人脐静脉内皮细胞单层经TNF-α激活,全血暴露于普通肝素联合或不联合IVIG后,以HIT样单克隆抗体K070或HIT患者IgG处理,在静脉剪切应力下灌注。
- 采用免疫荧光显微镜研究血栓结构与动态。
主要发现
- HIT患者IgG和K070在预防性肝素暴露下于TNF-α处理的内皮细胞上诱导血栓形成。
- HIT血栓富含纤维蛋白、携带磷脂酰丝氨酸的血小板和白细胞聚集体。
- 观察到血栓在黏附血小板上形成,逐渐招募白细胞形成三维血栓结构。
- IVIG预处理血液显著减少细胞黏附并预防血栓形成。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Heparin-induced thrombocytopenia (HIT) is a serious adverse reaction to heparin, associated with increased risk of thromboembolic complications. Intravenous immunoglobulins (IVIGs) have been used as a therapeutic for HIT and are believed to alleviate thrombocytopenia and reduce thrombosis risk. Yet the antithrombotic effects of IVIG in HIT remain underexplored. OBJECTIVE: To investigate the effect of IVIG on thrombus formation in an ex vivo model of HIT-IgG-induced thrombosis. METHODS: Microfluidic channels were coated with a confluent monolayer of human umbilical vein endothelial cells that were primed with TNF-α to induce an activated, inflammatory state. Whole blood was exposed to unfractionated heparin, with or without IVIG before subjecting to treatment with a monoclonal HIT-like antibody (K070), or HIT-patient-IgG. Recalcified blood was perfused over human umbilical vein endothelial cells at venous shear stress. Thrombus structure and dynamics were investigated by immunofluorescence microscopy. RESULTS: HIT-patient-IgGs and K070 induced thrombus formation in the presence of prophylactic heparin exposure, over TNF-α treated, inflamed endothelial cells. HIT thrombi were enriched in fibrin, phosphatidylserine-bearing platelets, and leukocyte aggregates. We observed thrombi being formed on adherent platelets, which gradually recruited leukocytes into a three-dimensional thrombus structure. Pretreatment of blood with IVIG significantly reduced cellular adhesions and prevented thrombus formation. CONCLUSION: Our endothelialized ex vivo flow chamber system effectively recapitulates the immunothrombotic phenotype of HIT and offers a reliable tool to urgently validate the efficacy of IVIG intervention against HIT-IgG-induced thrombosis in patients.
引用
- Witzemann A, Uzun G, Wolska N, et al. Intravenous immunoglobulin prevents thrombosis in an endothelialized disease model of heparin-induced thrombocytopenia. J Thromb Haemost. 2025. PMID: 39984158. doi:10.1016/j.jtha.2025.02.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。